Class Action Lawsuits Filed Against Rackspace Technology, Bloom Energy, Capricor Therapeutics, and Wise Group

LOS ANGELES, Sept. 15, 2026 /CourierPR/ -- The Law Offices of Frank R. Cruz has reminded investors of class action lawsuits filed on behalf of shareholders of four publicly-traded companies: Rackspace Technology, Inc. (NASDAQ: RXT), Bloom Energy Corporation (NYSE: BE), Capricor Therapeutics, Inc. (NASDAQ: CAPR), and Wise Group plc (NASDAQ: WSE). Investors who believe they have suffered losses due to these companies' alleged misrepresentations are encouraged to contact the law firm for more information.

Rackspace Technology, Inc. (NASDAQ: RXT)

Investors in Rackspace Technology are advised that a class action lawsuit has been filed against the company. The complaint alleges that throughout the period from May 7, 2026, to July 8, 2026, the company made materially false and misleading statements about its enterprise AI efforts and Public Cloud revenue. Specifically, the lawsuit claims that Rackspace failed to disclose that its AI initiatives would require significant re-prioritization of resources away from the profitable Private Cloud segment, and that Public Cloud revenue was declining due to customers contracting directly with hyperscale cloud platforms. As a result, the company was expected to significantly reduce its Public Cloud infrastructure resale business, leading to a significant impact on fiscal year 2026 revenue.

Bloom Energy Corporation (NYSE: BE)

Similarly, Bloom Energy Corporation is facing a class action lawsuit. The complaint states that the company made false and misleading statements about its scandium sourcing. According to the lawsuit, Bloom Energy obtained scandium through intermediaries who sourced the metal from China, but the company failed to disclose this information. This omission, the lawsuit argues, understated the extent to which the company relied on scandium from China, making its positive statements about the company's business, operations, and prospects materially misleading.

Capricor Therapeutics, Inc. (NASDAQ: CAPR)

Capricor Therapeutics, Inc. is also the subject of a class action lawsuit. The complaint alleges that the company failed to disclose significant changes to its statistical analysis plan used to analyze clinical data for Deramiocel, a drug for Duchenne muscular dystrophy. The lawsuit claims that the FDA had not agreed to these changes before the company resubmitted the Deramiocel Biologics License Application (BLA). As a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of the drug's effectiveness. This, the lawsuit argues, created a substantial risk to the regulatory approval of Deramiocel.

Wise Group plc (NASDAQ: WSE)

Lastly, Wise Group plc is facing a class action lawsuit. The complaint alleges that the company understated its regulatory risks, particularly in its anti-money laundering efforts and insufficient measures to prevent the financing of terrorism. According to the lawsuit, these deficiencies were material and led to the company's successful debut on the NASDAQ. The lawsuit claims that the company's positive statements about its business, operations, and prospects were materially false and misleading.

Investors who believe they have suffered losses due to these alleged misrepresentations are encouraged to contact The Law Offices of Frank R. Cruz. The firm can be reached at 310-914-5007 or by email at [email protected]. The deadline for filing a lead plaintiff motion is September 28, 2026, for Rackspace Technology, Bloom Energy Corporation, and Capricor Therapeutics, and September 29, 2026, for Wise Group plc.